Buy the Remedium Retatrutide 30mg Pen in Dubai from Remy Peptides — a research-grade prefilled pen device designed for precise dosing in laboratory protocols, 300 clicks at 0.1mg, no reconstitution. Janoshik tested at 99.262% HPLC, batch RETP002. Order before 4 PM for same-day Dubai delivery, next-day across the UAE. Research use only.
Reference price as of June 2026: AED 1,600 (1 pen) · AED 1,450/pen (2-pack) · AED 1,300/pen (5+ pack)
RETP002Retatrutide must not be frozen and should be protected from light and temperature fluctuations to preserve documented storage conditions.
Remy Peptides supplies the Remedium Retatrutide 30mg Pen in Dubai as seller and fulfilment contact for in-vitro laboratory research. Current price: AED 1,300–1,600 per pen. COA: Janoshik batch RETP002 at 99.262% HPLC, published at /coa/retp002/. Delivery: same-day Dubai, next-day UAE. Intended use: research use only, not for human or veterinary use.
We offer discounts for multi-pen orders.
RETP002The 30mg pen and a BPC-157 vial are the most-paired items in the catalog. Add both to the cart in one click.
Stabilised, prefilled, no reconstitution. Pen format only — for the 10mg/40mg vials, see the retatrutide format overview, and for everything else we stock browse the UAE peptides catalog. Trial titration schedule lives in the dosage guide.
Retatrutide (LY-3437943) is a unimolecular triple-agonist (informally a “triple-G” or GLP-3 agonist) designed to activate three distinct receptors — GLP-1, GIP, and glucagon — in published research. This simultaneous activation is the basis of its mechanism in metabolic research models and what separates it from single-agonist GLP-1 compounds (semaglutide) and dual-agonist GLP-1/GIP compounds (tirzepatide). At the GLP-1 receptor, research observes appetite-signalling suppression and slowed gastric emptying. GIP receptor activation enhances post-meal insulin response in published trial data. Glucagon receptor co-activation increases energy expenditure and mobilises stored substrates — the differentiator absent from approved single- and dual-agonist therapies. Published retatrutide trials track endpoints such as body composition, lean mass, glycaemic markers, and BMI. See the peptide research glossary for RUO terminology used on this product page.
Three receptors in one molecule. Comparison data against semaglutide and tirzepatide lives in the research hub. Phase 2 outcome figures and Phase 3 status are tracked on the approval page and the TRIUMPH tracker.
The Remedium Retatrutide 30mg Pen ships pre-mixed and pH-balanced. No reconstitution, no measuring.
Each click is 0.1 mg. See the dosage guide for the trial titration schedule, the calculator for pen-duration planning, and the Retatrutide UAE format map for batch-by-batch COA context.
Equilibrate at room temperature for 5–10 minutes out of cold storage. Return to 2–8 °C between sessions. Do not freeze. For in-vitro laboratory research only — UAE MoHAP Circular 17/2022.
Click-to-mg conversions and titration schedules are documented separately: pen clicks chart, dosage guide, and the pen-duration calculator.
Each Remedium Retatrutide 30mg Pen batch sold by Remy Peptides is independently tested by Janoshik Analytical — a leading third-party laboratory specialising in pharmaceutical purity analysis. HPLC confirms compound identity and concentration: the current flagship batch RETP002 is verified at 99.262% HPLC, and the batch-specific report ships with each order.
Each click delivers 0.1 mg. The 30mg pen contains 300 clicks total. The full mg-to-click lookup is in the pen clicks guide; for any custom dose or extended click sequences, open the retatrutide calculator.
Remedium Retatrutide 30mg Pen ships from Remy Peptides with a batch-matched Janoshik COA at 99.262% HPLC, AED 1,300–1,600/pen, same-day Dubai dispatch before 4 PM and next-day tracked cold-chain across the UAE, with a tracking number for every order. Other stocked retatrutide formats: 20mg pen, 10mg pen, 40mg pen, 10mg vial, and 40mg vial. For dual-agonist research-vial comparison outside the retatrutide line, see the tirzepatide 40mg vial. For Research Use Only.
Purchasing retatrutide from unregulated sources online carries real risk — unknown purity, missing or mismatched COAs, and unverified chain of custody. Every Remedium Retatrutide 30mg Pen sold by Remy Peptides ships with a public, batch-linked Janoshik Analytical report and verifiable contact channels at contact verification. See how UAE sellers compare on published purity in our best retatrutide supplier Dubai guide.
4.7/5 average from 3 verified customer reviews.
“The 30mg pen arrived cold, sealed, and exactly as shown. Support answered quickly and delivery was faster than I expected.”
“Good product and very smooth service. I liked that the Janoshik COA details were easy to check before ordering.”
“Packaging was clean and professional, and the pen came in good condition. WhatsApp support made the whole order simple.”
Verified Remy Peptides customers. Feedback reflects product quality, packaging, delivery, and service experience only. It is not a therapeutic, dosing, or research-outcome claim. For Research Use Only.
Buy the Remedium Retatrutide 30mg Pen from Remy Peptides. Remy Peptides is the seller and fulfilment contact for this listing — order online or finalize on WhatsApp. AED 1,600 single, AED 1,450/pen at 2-pack, AED 1,300/pen at 5+ pack. Pay-on-delivery, card, or USDT. Free tracked delivery: same-day Dubai before 4 PM, next-day UAE-wide, with a tracking number for every order.
From Remy Peptides at Pinnacle Building, Al Barsha 1, Dubai. Buy reta in any format — pen or lyophilized vial — with batch-matched Janoshik COA, tracked cold-chain shipping to all seven emirates, and verified contact channels at contact verification.
From AED 1,300/pen (5+ pack), AED 1,450/pen (2-pack), AED 1,600 for a single pen. Janoshik-verified at 99.262% HPLC, free tracked UAE delivery.
From Remy Peptides at Pinnacle Building, Al Barsha 1, Dubai. WhatsApp to confirm. Same-day Dubai dispatch, next-day to all emirates.
Yes, for in-vitro laboratory research only under UAE MoHAP Circular 17/2022. Not approved for human or veterinary use.
99.262% HPLC, Janoshik Analytical batch RETP002. Full COA published at /coa/retp002/.
Our peptides are produced by a GMP-certified manufacturing partner using fully automated synthesis equipment and advanced analytical instruments, including UPLC and high-resolution mass spectrometry. Every batch is then independently verified by Janoshik Analytical before release, so you rely on third-party data rather than vendor-only claims. Supplied for research use only.
Retatrutide (LY-3437943) is a GLP-1 / GIP / glucagon triple-agonist peptide. Mechanism and clinical context are covered in the research hub.
Phase 2 outcome figures and Phase 3 status are tracked on the TRIUMPH trial tracker. We don't publish efficacy claims on product pages.
Published trial side-effect data is summarised in the safety & adverse-event section of the retatrutide profile. Not a clinical reference.
Each 30mg pen ships pre-mixed and pH-balanced. Box: 1 prefilled pen, 20 pen dispensing needles (31G, 5mm), instruction leaflet, batch-matched Janoshik COA. No reconstitution. Powder vials are a separate format — see the format overview.
2–8 °C refrigerated, protected from light, never frozen. Ships in insulated cold-chain packaging with ice packs and a temperature indicator.
No. Retatrutide is in Phase 3 trials (Eli Lilly TRIUMPH programme). Full status on the approval tracker. Supplied for research only.
Dubai orders placed before 4 PM ship same-day. Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, and Umm Al Quwain receive next-day delivery. Insulated packaging, ice packs, temperature indicator — 2–8 °C from Dubai stock.
Every order ships with a full Janoshik Analytical Certificate of Analysis for batch RETP002, verified at 99.262% HPLC purity. All COAs are publicly accessible on the COA library, and active WhatsApp, Telegram, and Instagram channels can be confirmed via contact verification. No batch is sold without completed third-party verification — review the full research standards for the screening flow.
Retatrutide’s triple-agonist mechanism (GLP-1, GIP, glucagon) acts on multiple metabolic pathways simultaneously. Phase 2 trial data has reported improvements in insulin sensitivity, glycaemic markers, and lipid metabolism alongside the primary weight-reduction signal. Full mechanism notes live in the research hub; outcome data is summarised on the approval status page and the TRIUMPH trial tracker.
Published TRIUMPH retatrutide trial protocols report a weekly schedule with stepwise titration, escalating every four weeks in the trial design. This is published trial-protocol context only — not administration guidance. The 30mg pen delivers 0.1mg per click (300 clicks total), which lines up cleanly with click-based titration modelling. Full titration steps from the published protocols are documented in the retatrutide dosage guide; for click-to-mg conversions see the pen clicks chart; plan pen counts against your protocol with the retatrutide calculator.
300 clicks total. The 30mg pen contains 300 × 0.1mg = 30mg of Retatrutide. Each click delivers 0.1mg minimum increment. For mg-to-click conversion across all common doses see the pen clicks guide, or open the calculator for any custom dose.
Remy Peptides sells and fulfils Remedium Retatrutide 30mg Pen orders from Dubai (Pinnacle Building, Al Barsha 1). Order on the product page or finalize on WhatsApp at +351 924 694 686 — same-day Dubai dispatch before 4 PM, next-day UAE-wide, tracking number included.
AED 1,300–1,600 per pen, with volume tiers shown on the product page. Pricing valid through 2026-12-31.
Yes — every 30mg pen sold by Remy Peptides ships with the published Janoshik COA for batch RETP002 (99.262% HPLC). Public COA at https://remypeptides.com/coa/retp002/.
Yes. Remedium Retatrutide 30mg Pen is supplied strictly for in-vitro laboratory research under UAE MoHAP Circular 17/2022. Not for human or veterinary use.
The Remedium Retatrutide 30mg Pen is a prefilled pen device with 0.1mg-per-click dialled increments, used in in-vitro laboratory research protocols only. The dial caps at 6mg per single increment — full click-to-mg lookup is in the pen clicks guide.
The Remedium Retatrutide 30mg Pen is intended for laboratory researchers and verified research buyers operating under UAE MoHAP Circular 17/2022. It is not for clinical, personal, or veterinary use.
Linked resources for the 30mg pen: dosage guide (trial titration schedule), pen clicks chart (mg-to-click lookup), retatrutide calculator (custom dose & pen-count planning), batch RETP002 COA, and the full COA library.
The 30mg FlexiPen is the full-size format. To buy retatrutide in smaller pen sizes or lyophilized vials — 10mg, 20mg, and 40mg — the catalog covers labs that reconstitute their own. German-language buyers can use the Retatrutide kaufen page.
10mg lyophilized vial · triple-agonist LY-3437943 · cold-chain
40mg lyophilized vial · triple-agonist LY-3437943 · cold-chain
40mg FlexiPen · 300 clicks @ 0.133mg · Pre-filled
Browse research stacks → — the flagship pen pairs with BPC-157 in the Pen + BPC Pair at 5% off.